QuidelOrtho Corp. (QDEL)
12.58
+0.44
(+3.62%)
USD |
NASDAQ |
Oct 06, 16:00
12.58
0.00 (0.00%)
After-Hours: 19:00
QuidelOrtho Cash from Investing (Quarterly) : -107.30M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -107.30M |
| March 31, 2026 | -34.00M |
| December 31, 2025 | -49.60M |
| September 30, 2025 | -53.90M |
| June 30, 2025 | -33.00M |
| March 31, 2025 | -56.20M |
| December 31, 2024 | -37.90M |
| September 30, 2024 | -56.50M |
| June 30, 2024 | -35.30M |
| March 31, 2024 | -20.20M |
| December 31, 2023 | -55.10M |
| September 30, 2023 | -21.30M |
| June 30, 2023 | -42.30M |
| March 31, 2023 | -68.90M |
| December 31, 2022 | -59.30M |
| September 30, 2022 | -29.80M |
| June 30, 2022 | -1.530B |
| March 31, 2022 | -24.67M |
| December 31, 2021 | -96.01M |
| September 30, 2021 | -93.24M |
| June 30, 2021 | -65.70M |
| March 31, 2021 | -64.57M |
| December 31, 2020 | -27.21M |
| September 30, 2020 | -22.72M |
| June 30, 2020 | -7.504M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.884M |
| December 31, 2019 | -8.513M |
| September 30, 2019 | -6.932M |
| June 30, 2019 | -6.791M |
| March 31, 2019 | -4.993M |
| December 31, 2018 | -8.814M |
| September 30, 2018 | -9.298M |
| June 30, 2018 | -8.628M |
| March 31, 2018 | 141.70M |
| December 31, 2017 | -404.60M |
| September 30, 2017 | -4.43M |
| June 30, 2017 | -19.01M |
| March 31, 2017 | -3.712M |
| December 31, 2016 | -4.049M |
| September 30, 2016 | -2.403M |
| June 30, 2016 | -3.423M |
| March 31, 2016 | -7.095M |
| December 31, 2015 | -5.029M |
| September 30, 2015 | -4.655M |
| June 30, 2015 | -4.481M |
| March 31, 2015 | -2.867M |
| December 31, 2014 | -2.657M |
| September 30, 2014 | -1.873M |
| June 30, 2014 | -2.652M |
| March 31, 2014 | -4.059M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | -25.50M |
| Neogen Corp. | -4.00M |
| Aspira Women's Health, Inc. | -0.15M |
| VolitionRX Ltd. | -0.0016M |
| Lucid Diagnostics, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -110.60M |
| Cash from Financing (Quarterly) | 200.60M |
| Free Cash Flow | -211.20M |
| Free Cash Flow Per Share (Quarterly) | -1.993 |
| Free Cash Flow to Equity (Quarterly) | -336.80M |
| Free Cash Flow to Firm (Quarterly) | -73.86M |
| Free Cash Flow Yield | -24.64% |